Role of FLT3 inhibitors as maintenance following transplant in AML

The use of gilteritinib in post-transplant maintenance for AML with FLT3-ITDПодробнее

The use of gilteritinib in post-transplant maintenance for AML with FLT3-ITD

Acute Myeloid Leukemia and the Role of FLT3 Inhibitors: Best Practices for the Interprofessional ...Подробнее

Acute Myeloid Leukemia and the Role of FLT3 Inhibitors: Best Practices for the Interprofessional ...

Randomised trial of the FLT3 inhibitor gilteritinib as post-transplant maintenance for FLT3-ITD AMLПодробнее

Randomised trial of the FLT3 inhibitor gilteritinib as post-transplant maintenance for FLT3-ITD AML

Maintenance Therapy after Transplant: Acute Myeloid Leukemia (AML)Подробнее

Maintenance Therapy after Transplant: Acute Myeloid Leukemia (AML)

Optimising transplant outcome in adults allografted for AMLПодробнее

Optimising transplant outcome in adults allografted for AML

New Findings and Improved Outcomes in the Treatment of AMLПодробнее

New Findings and Improved Outcomes in the Treatment of AML

FLT3 inhibitor maintenance after allo-SCT for AMLПодробнее

FLT3 inhibitor maintenance after allo-SCT for AML

Indications for allogeneic stem cell transplantation in AMLПодробнее

Indications for allogeneic stem cell transplantation in AML

FLT3 inhibitors - their role in AMLПодробнее

FLT3 inhibitors - their role in AML

Актуальное